Orexin-B

Orexin-B is a peptide that has only been studied in preclinical or mechanistic research, with no clinical trials in humans. Consequently, community interest revolves around off‑label or compounded use, as there is no FDA‑approved indication to guide legitimate prescribing. No side effects have been reported in community data, and potential concerns such as injection‑site reactions, histamine‑type flush, sleep changes, edema, nausea or GI upset have not surfaced as consistent themes; the core tradeoff remains that all human use is off‑label or compounded, lacking regulatory oversight and formal safety data.

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyno dataAnecdotalSideEffectsno dataPrice0.41.0

Measured on 2 of 6 axes

Research Evidence

Evidence shape

Orexin-B has zero human published studies, so its evidence is classified as animal-only, with preclinical/mechanistic research listed as the only indication. The dataset records zero registered trials, a single animal-only indication, and no completed trials, which together indicate an absence of any human clinical data. Because there are no published human studies, no trial results, and no registered trials, the peptide lacks the breadth and quality of evidence required to support claims about human use.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth15 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
3
HighMediumLow

Anecdotal efficacy

Orexin-B side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Symptom-relevant clinical or community evidence has not been captured for this peptide yet.

Price

Full buying guide →
1
Rp Peptides
GB
5 mg
$68.46
$13.69/mg
2
BehemothLabz
USA
5 mg
$261.96
$52.39/mg
3
Pure Rawz
--
5 mg
$262.08
$52.42/mg

price offers can be sorted by column

Dosing & Protocol

Dosing protocol not projected for this peptide yet.

Related peptides

DSIPOrexin-A